News
Medical device maker Medtronic plcMDT recently announced the receipt of FDA approval for its Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D) SureScan device for the treatment ...
Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - New data from the Medtronic, Inc.
Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...
LONDON, LivaNova PLC a market-leading medical technology company, announced today the launch of PLATINIUM, its next-generation range of implantable cardiac defibrillators (ICDs) and cardiac ...
“With PLATINIUM we are definitively entering a new era for ICD and CRT-D devices. PLATINIUM’s unsurpassed longevity 1 will benefit all patients, both those who, thanks to the efforts of the medical ...
“This new device platform provides a number of new features that will help me to improve management of my patients with ICD and CRT-D devices, while delivering new safety features on top of St. Jude ...
RMH electrophysiologist Robert VerNooy, MD, has successfully implanted a new type of heart pacing device that helps doctors better treat patients diagnosed with heart failure. He is the first ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...
A combination defibrillator and cardiac resynchronization device reduced deaths by nearly one-third in patients with mild heart failure in a study that was terminated early on Monday because of its ...
March 6, 2009 (Washington, DC) — In a national registry for patients with implantable cardioverter-defibrillators (ICDs), among those also eligible for cardiac resynchronization therapy (CRT), ...
ABBOTT PARK, Ill., Jan. 3, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for the Quadra ...
Indianapolis, IN - After consultations with the US Food and Drug Administration about reported problems with some of its implantable cardioverter defibrillator (ICD) and cardiac resynchronization ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results